Frontier Capital Management’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-77,561
| Closed | -$2.98M | – | 284 |
|
|
2024
Q2 | $2.98M | Sell |
77,561
-487
| -0.6% | -$18.7K | 0.03% | 261 |
|
|
2024
Q1 | $4.59M | Buy |
+78,048
| New | +$4.59M | 0.04% | 252 |
|
|
2023
Q4 | – | Sell |
-34,600
| Closed | -$1.32M | – | 264 |
|
|
2023
Q3 | $1.32M | Buy |
+34,600
| New | +$1.32M | 0.01% | 255 |
|
|
2022
Q4 | – | Sell |
-6,193
| Closed | -$423K | – | 264 |
|
|
2022
Q3 | $423K | Buy |
6,193
+133
| +2% | +$9.08K | 0.01% | 265 |
|
|
2022
Q2 | $274K | Sell |
6,060
-9,489
| -61% | -$429K | ﹤0.01% | 274 |
|
|
2022
Q1 | $790K | Sell |
15,549
-107,941
| -87% | -$5.48M | 0.01% | 265 |
|
|
2021
Q4 | $5.84M | Sell |
123,490
-152,420
| -55% | -$7.21M | 0.05% | 249 |
|
|
2021
Q3 | $9.09M | Buy |
275,910
+98,385
| +55% | +$3.24M | 0.07% | 225 |
|
|
2021
Q2 | $11.2M | Buy |
+177,525
| New | +$11.2M | 0.08% | 227 |
|